Inozyme Pharma, Inc.
INZY
Revenue
0.00
0.000.00%
-Assets
155.71M
▼-21.23M▼-12.00%
3 Months ChangeLiabilities
61.29M
▲3.19M▲5.48%
3 Months ChangeFree Cash Flow
-24.57M
▼-6.62M▼-36.88%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0000950170-24-117087
2024-10-07
Form 8-K
ID: 0000950170-24-113241
2024-08-06
Form 8-K
ID: 0001193125-24-194957
2024-08-06
Form 10-Q
ID: 0000950170-24-091230
2024-08-06
Form 8-K
ID: 0000950170-24-091227
2024-06-20
Form 8-K
ID: 0000950170-24-075598
2024-05-07
Form 10-Q
ID: 0000950170-24-053981
2024-05-07
Form 8-K
ID: 0000950170-24-053979
2024-04-08
Form 8-K
ID: 0001193125-24-089091
2024-03-12
Form 8-K
ID: 0000950170-24-029672